Story · Medicine & Biotech · Health Tech
Vivek Subbiah: Exploring AI-Based Prediction of Actionable Genomic Alterations From H&E-Stained Slides
1 outlet · first reported by OncoDaily on
Vivek Subbiah, Director of Early Phase Drug Development Program at NYU Langone Health, shared on LinkedIn: “Your Outlook email may not be working and your flight may be delayed so (OncoDaily)
Coverage, in order
-
Vivek Subbiah: Exploring AI-Based Prediction of Actionable Genomic Alterations From H&E-Stained SlidesVivek Subbiah, Director of Early Phase Drug Development Program at NYU Langone Health, shared on LinkedIn: “Your Outlook email may not be working and your flight may be delayed so
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.